- Haotian Lin
(State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University)
- Hong Ouyang
(State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University)
- Jie Zhu
(Shiley Eye Institute, Institute for Engineering in Medicine, Institute for Genomic Medicine, University of California)
- Shan Huang
(State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University)
- Zhenzhen Liu
(State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University)
- Shuyi Chen
(State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University)
- Guiqun Cao
(Molecular Medicine Research Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University)
- Gen Li
(Molecular Medicine Research Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University
Guangzhou KangRui Biological Pharmaceutical Technology Company)
- Robert A. J. Signer
(Howard Hughes Medical Institute, Children’s Research Institute, University of Texas Southwestern Medical Center)
- Yanxin Xu
(Molecular Medicine Research Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University
West China Hospital, Sichuan University)
- Christopher Chung
(Shiley Eye Institute, Institute for Engineering in Medicine, Institute for Genomic Medicine, University of California)
- Ying Zhang
(Brigham and Women’s Hospital and Harvard Medical School)
- Danni Lin
(Shiley Eye Institute, Institute for Engineering in Medicine, Institute for Genomic Medicine, University of California)
- Sherrina Patel
(Shiley Eye Institute, Institute for Engineering in Medicine, Institute for Genomic Medicine, University of California)
- Frances Wu
(Shiley Eye Institute, Institute for Engineering in Medicine, Institute for Genomic Medicine, University of California)
- Huimin Cai
(Molecular Medicine Research Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University
Guangzhou KangRui Biological Pharmaceutical Technology Company)
- Jiayi Hou
(Clinical and Translational Research Institute, University of California)
- Cindy Wen
(Shiley Eye Institute, Institute for Engineering in Medicine, Institute for Genomic Medicine, University of California)
- Maryam Jafari
(Shiley Eye Institute, Institute for Engineering in Medicine, Institute for Genomic Medicine, University of California)
- Xialin Liu
(State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University)
- Lixia Luo
(State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University)
- Jin Zhu
(Shiley Eye Institute, Institute for Engineering in Medicine, Institute for Genomic Medicine, University of California)
- Austin Qiu
(Shiley Eye Institute, Institute for Engineering in Medicine, Institute for Genomic Medicine, University of California)
- Rui Hou
(Guangzhou KangRui Biological Pharmaceutical Technology Company)
- Baoxin Chen
(State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University)
- Jiangna Chen
(State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University)
- David Granet
(Shiley Eye Institute, Institute for Engineering in Medicine, Institute for Genomic Medicine, University of California)
- Christopher Heichel
(Shiley Eye Institute, Institute for Engineering in Medicine, Institute for Genomic Medicine, University of California)
- Fu Shang
(State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University)
- Xuri Li
(State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University)
- Michal Krawczyk
(Shiley Eye Institute, Institute for Engineering in Medicine, Institute for Genomic Medicine, University of California)
- Dorota Skowronska-Krawczyk
(Shiley Eye Institute, Institute for Engineering in Medicine, Institute for Genomic Medicine, University of California)
- Yujuan Wang
(State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University)
- William Shi
(Shiley Eye Institute, Institute for Engineering in Medicine, Institute for Genomic Medicine, University of California)
- Daniel Chen
(Shiley Eye Institute, Institute for Engineering in Medicine, Institute for Genomic Medicine, University of California)
- Zheng Zhong
(State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University
Shiley Eye Institute, Institute for Engineering in Medicine, Institute for Genomic Medicine, University of California)
- Sheng Zhong
(Shiley Eye Institute, Institute for Engineering in Medicine, Institute for Genomic Medicine, University of California)
- Liangfang Zhang
(Shiley Eye Institute, Institute for Engineering in Medicine, Institute for Genomic Medicine, University of California)
- Shaochen Chen
(Shiley Eye Institute, Institute for Engineering in Medicine, Institute for Genomic Medicine, University of California)
- Sean J. Morrison
(Howard Hughes Medical Institute, Children’s Research Institute, University of Texas Southwestern Medical Center)
- Richard L. Maas
(Brigham and Women’s Hospital and Harvard Medical School)
- Kang Zhang
(State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University
Shiley Eye Institute, Institute for Engineering in Medicine, Institute for Genomic Medicine, University of California
Molecular Medicine Research Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University
Veterans Administration Healthcare System)
- Yizhi Liu
(State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University)